Publications by authors named "P Hereu"
Background: The increasing use of non-specific immunoglobulins (NSIGs) and their current shortage show a need for NSIGs' use prioritization. Data from a clinical perspective are necessary, mainly for pediatric patients.
Objectives: The aim of the study was to assess the level of clinical evidence (LoE) of the indications that NSIGs are used for, the reasons for discontinuation, and the costs invested.
Article Synopsis
- Acute pancreatitis (AP) is an inflammatory condition with various causes, including drugs, which account for a small percentage of cases; diagnosing drug-induced AP is often complicated due to a lack of specific symptoms.
- A study conducted at Hospital Universitari de Bellvitge analyzed 38 patients with suspected drug-induced AP from June 2007 to March 2023, revealing that most cases were linked to a single drug, with azathioprine and atorvastatin being the most common culprits.
- The findings suggest that increased awareness and a proposed diagnostic algorithm may improve the identification and management of drug-induced pancreatitis, highlighting the need for drug assessment when diagnosing AP.
To explore preoperative and operative risk factors for red blood cell (RBC) transfusion requirements during liver transplantation (LT) and up to 24 h afterwards. We evaluated the associations between risk factors and units of RBC transfused in 176 LT patients using a log-binomial regression model. Relative risk was adjusted for age, sex, and the model for end-stage liver disease score (MELD) (adjustment 1) and baseline hemoglobin concentration (adjustment 2).
View Article and Find Full Text PDFBackground: Lumen-apposing metal stents (LAMS) have displaced double-pigtail plastic stents (DPS) as the standard treatment for walled-off necrosis (WON),β but evidence for exclusively using LAMS is limited. We aimed to assess whether the theoretical benefit of LAMS was superior to DPS.
Methods: This multicenter, open-label, randomized trial was carried out in 9 tertiary hospitals.
Treatment failure occurs in about 25% of patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia. We assessed whether cloxacillin plus fosfomycin achieves better treatment success than cloxacillin alone in hospitalized adults with MSSA bacteremia. We conducted a multicenter, open-label, phase III-IV superiority randomized clinical trial.
View Article and Find Full Text PDF